Prospective Multidisciplinary Post-COVID-19 Registry Tyrol
NCT ID: NCT05545332
Last Updated: 2022-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
600 participants
OBSERVATIONAL
2022-03-03
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Follow-up of Patients With Previous SARS-CoV-2 Infection: Long-term Damage Assessment
NCT05359159
Austrian COVID-19 Registry
NCT04351529
Evaluation of Inflammatory Cytokines During COVID-19
NCT04824495
Survey of Incidence of Respiratory Tract Infections
NCT06649032
Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19
NCT04581135
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
With this prospective multidisciplinary registry, the investigators aim to establish a clinical and researchbased system by providing optimized medical diagnostic and therapeutic approaches in a model region in Austria (Tyrol).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* post COVID functional status scale (PCFS) ≥ 2
Exclusion Criteria
* PCFS \< 2
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University Innsbruck
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Innsbruck
Innsbruck, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Judith Löffler-Ragg, Prof. Dr.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1450/2021_V2_10_02_2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.